Css LLC Il Acquires 90 Shares of Cardinal Health, Inc. (NYSE:CAH)

Css LLC Il lifted its holdings in Cardinal Health, Inc. (NYSE:CAH) by 0.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,190 shares of the company’s stock after acquiring an additional 90 shares during the period. Css LLC Il’s holdings in Cardinal Health were worth $1,323,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Geode Capital Management LLC increased its position in shares of Cardinal Health by 1.9% during the 4th quarter. Geode Capital Management LLC now owns 5,859,132 shares of the company’s stock valued at $691,145,000 after purchasing an additional 109,273 shares during the last quarter. Invesco Ltd. increased its position in Cardinal Health by 4.6% during the fourth quarter. Invesco Ltd. now owns 3,182,514 shares of the company’s stock valued at $376,396,000 after acquiring an additional 140,368 shares during the last quarter. Marshall Wace LLP raised its stake in shares of Cardinal Health by 154.6% in the fourth quarter. Marshall Wace LLP now owns 3,151,736 shares of the company’s stock valued at $372,756,000 after acquiring an additional 1,913,892 shares during the period. Northern Trust Corp raised its stake in shares of Cardinal Health by 16.2% in the fourth quarter. Northern Trust Corp now owns 3,037,849 shares of the company’s stock valued at $359,286,000 after acquiring an additional 422,755 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Cardinal Health by 4.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,321,797 shares of the company’s stock worth $274,599,000 after acquiring an additional 94,768 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Performance

NYSE CAH opened at $154.71 on Wednesday. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $156.44. The company has a market capitalization of $36.93 billion, a price-to-earnings ratio of 28.86, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. The company’s 50-day simple moving average is $138.20 and its two-hundred day simple moving average is $128.37.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.15 by $0.20. The company had revenue of $54.88 billion for the quarter, compared to analyst estimates of $55.33 billion. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Cardinal Health’s revenue was up .0% compared to the same quarter last year. During the same period last year, the company posted $2.08 earnings per share. Equities analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be issued a $0.5107 dividend. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.32%. The ex-dividend date is Tuesday, July 1st. Cardinal Health’s dividend payout ratio (DPR) is currently 31.83%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Mizuho increased their price objective on shares of Cardinal Health from $142.00 to $150.00 and gave the stock an “outperform” rating in a research report on Monday, March 31st. Bank of America increased their price target on Cardinal Health from $150.00 to $155.00 and gave the stock a “buy” rating in a report on Friday, April 11th. Wells Fargo & Company boosted their price objective on Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Jefferies Financial Group upgraded Cardinal Health from a “hold” rating to a “buy” rating and increased their target price for the stock from $140.00 to $150.00 in a research note on Wednesday, February 5th. Finally, Argus set a $148.00 target price on shares of Cardinal Health in a research note on Tuesday, February 4th. Four analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $146.43.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.